Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
US Department of Justice
Fuji
UBS
Daiichi Sankyo
McKinsey
Cantor Fitzgerald
Johnson and Johnson
Queensland Health

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019675

« Back to Dashboard

NDA 019675 describes ZANTAC, which is a drug marketed by Teligent, Glaxo Grp Ltd, Glaxosmithkline, and Sanofi Us, and is included in nine NDAs. It is available from one supplier. Additional details are available on the ZANTAC profile page.

The generic ingredient in ZANTAC is ranitidine hydrochloride. There are forty-three drug master file entries for this compound. One hundred and forty-five suppliers are listed for this compound. Additional details are available on the ranitidine hydrochloride profile page.
Summary for 019675
Tradename:ZANTAC
Applicant:Glaxo Grp Ltd
Ingredient:ranitidine hydrochloride
Patents:0
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SYRUP;ORALStrengthEQ 15MG BASE/ML
Approval Date:Dec 30, 1988TE:AARLD:Yes

Expired US Patents for NDA 019675

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxo Grp Ltd ZANTAC ranitidine hydrochloride SYRUP;ORAL 019675-001 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd ZANTAC ranitidine hydrochloride SYRUP;ORAL 019675-001 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd ZANTAC ranitidine hydrochloride SYRUP;ORAL 019675-001 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Glaxo Grp Ltd ZANTAC ranitidine hydrochloride SYRUP;ORAL 019675-001 Dec 30, 1988 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Accenture
Fish and Richardson
QuintilesIMS
Moodys
Julphar
Deloitte
Cipla
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.